(BMRN) Biomarin - Performance -28.5% in 12m
BMRN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-53.52%
#76 in Peer-Group
Rel. Strength
16.76%
#6390 in Stock-Universe
Total Return 12m
-28.52%
#97 in Peer-Group
Total Return 5y
-52.72%
#65 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 21.3 |
| P/E Forward | 13.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 93.84 USD |
| 52 Week Low | 54.08 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 85.63 |
| Buy/Sell Signal +-5 | -1.33 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BMRN (-28.5%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: BMRN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BMRN
| Total Return (including Dividends) | BMRN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.33% | 3.64% | 4.08% |
| 3 Months | 4.44% | 23.43% | 19.65% |
| 12 Months | -28.52% | -7.41% | 12.88% |
| 5 Years | -52.72% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | BMRN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 33% | 30.3% | 86.9% |
| 3 Months | -67.4% | 79.4% | 97.2% |
| 12 Months | -80.7% | -87.3% | 46% |
| 5 Years | -16.6% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th57.00 | -1.27% | -1.68% |
| 3 Month | %th23.50 | -15.39% | -12.72% |
| 12 Month | %th52.50 | -22.80% | -36.68% |
| 5 Years | %th68.00 | -40.35% | -77.85% |
FAQs
Does Biomarin (BMRN) outperform the market?
No,
over the last 12 months BMRN made -28.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months BMRN made 4.44%, while XBI made 23.43%.
Performance Comparison BMRN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BMRN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.2% | -1.8% | -21.2% | -41% |
| US NASDAQ 100 | QQQ | 2.4% | -1.8% | -22.5% | -40% |
| German DAX 40 | DAX | 0.1% | 0.5% | -33.2% | -61% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.8% | -2.9% | -25.5% | -49% |
| Hongkong Hang Seng | HSI | 3.4% | -0.2% | -41.4% | -66% |
| India NIFTY 50 | INDA | 3.2% | 2.3% | -20.6% | -27% |
| Brasil Bovespa | EWZ | 7.7% | 0.5% | -37.2% | -31% |
BMRN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.5% | 0.2% | -24.7% | -51% |
| Consumer Discretionary | XLY | 2.2% | -0.2% | -13.4% | -45% |
| Consumer Staples | XLP | 3.6% | 2.4% | -20.2% | -36% |
| Energy | XLE | 0.4% | -2.8% | -14.7% | -31% |
| Financial | XLF | 3.2% | -1.3% | -24.9% | -56% |
| Health Care | XLV | 1.7% | 1.4% | -11.2% | -23% |
| Industrial | XLI | 1.4% | -2.6% | -28.2% | -54% |
| Materials | XLB | 1.3% | -2% | -24.6% | -35% |
| Real Estate | XLRE | 2.8% | 2.9% | -20.6% | -40% |
| Technology | XLK | 2.3% | -4.5% | -25.4% | -37% |
| Utilities | XLU | 1.4% | -0.5% | -23.5% | -51% |
| Aerospace & Defense | XAR | 1.9% | -4.2% | -39.3% | -77% |
| Biotech | XBI | -1.4% | -1.3% | -11.5% | -21% |
| Homebuilder | XHB | -1.1% | -6% | -16.8% | -35% |
| Retail | XRT | 1.9% | -0.4% | -15.6% | -40% |
BMRN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2% | -2.96% | -6.19% | -22% |
| Natural Gas | UNG | 5.6% | 10.5% | 7.2% | -24% |
| Gold | GLD | 2.6% | 2.5% | -36.1% | -68% |
| Silver | SLV | 1.6% | 0.8% | -34.9% | -48% |
| Copper | CPER | -6.8% | -11% | -42.1% | -51% |
BMRN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.3% | 0.7% | -16.7% | -26% |
| iShares High Yield Corp. Bond | HYG | 2.6% | 1.1% | -17.7% | -38% |